Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
parent cohort
\-- COPD diagnosis
child cohort
\-- any initiation of first maintenance therapy after July 1, 2015
grandchild cohort -- any initiation of second maintenance therapy after August 2, 2015
You may not be if
\- parent cohort
age \<40 on index date
any COPD diagnosis in baseline
any use of long-acting muscarinic antagonists (LAMA), long-acting beta-agonists (LABA), or inhaled corticosteroid (ICS) in baseline
\<365 days of continuous medical and pharmacy coverage
Clareo Health | Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study
